Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Vpr is a conserved primate lentiviral protein that promotes infection of T lymphocytes in vivo by an unknown mechanism. Here we demonstrate that Vpr and its cellular co-factor, DCAF1, are necessary for efficient cell-to-cell spread of HIV-1 from macrophages to CD4+ T lymphocytes when there is inadequate cell-free virus to support direct T lymphocyte infection. Remarkably, Vpr functioned to counteract a macrophage-specific intrinsic antiviral pathway that targeted Env-containing virions to LAMP1+ lysosomal compartments. This restriction of Env also impaired virological synapses formed through interactions between HIV-1 Env on infected macrophages and CD4 on T lymphocytes. Treatment of infected macrophages with exogenous interferon-alpha induced virion degradation and blocked synapse formation, overcoming the effects of Vpr. These results provide a mechanism that helps explain the in vivo requirement for Vpr and suggests that a macrophage-dependent stage of HIV-1 infection drives the evolutionary conservation of Vpr.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MR recognition of HIV Env disrupts infection by promoting lysosomal degradation of Env and Env-containing viral particles33,35.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We previously reported that Vpr counteracts accelerated degradation of the HIV Env protein, which occurs in HIV-infected macrophages but not T cells33,34.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Connor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
O'Doherty, U., Swiggard, W. J., & Malim, M. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10074-10080.2000 · Cited by 664
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
HIV-1 Cell to Cell Transfer across an Env-induced, Actin-dependent Synapse
Jolly, C., Kashefi, K., Hollinshead, M., & Sattentau, Q. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030648 · Cited by 623
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., & Emerman, M. (1998) · Nature Medicine · doi:10.1038/nm0198-065 · Cited by 518
Rogel, M. E., Wu, L. I., & Emerman, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.882-888.1995 · Cited by 406
Li, Y., Kappes, J. C., Conway, J. A., Price, R. W., Shaw, G. M., & Hahn, B. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.3973-3985.1991 · Cited by 378
Collman, R., Balliet, J. W., Gregory, S. A., Friedman, H., Kolson, D. L., Nathanson, N., & Srinivasan, A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7517-7521.1992 · Cited by 358
Carter, C. C., Onafuwa-Nuga, A., McNamara, L. A., Riddell, J., Bixby, D., Savona, M. R., & Collins, K. L. (2010) · Nature Medicine · doi:10.1038/nm.2109 · Cited by 317
Self-citationImmune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Kirchhoff, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.004 · Cited by 315
Sullivan, N., Sun, Y., Li, J., Hofmann, W., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4413-4422.1995 · Cited by 292
Le Rouzic, E., Belaïdouni, N., Estrabaud, E., Morel, M., Rain, J.-C., Transy, C., & Margottin-Goguet, F. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3732 · Cited by 267
Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses
Groot, F., Welsch, S., & Sattentau, Q. J. (2008) · Blood · doi:10.1182/blood-2007-12-130070 · Cited by 251
Balliet, J. W., Kolson, D. L., Eiger, G., Kim, F. M., McGann, K. A., Srinivasan, A., & Collman, R. (1994) · Virology · doi:10.1006/viro.1994.1225 · Cited by 236
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus
Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Müller, J., Müller-Hermelink, H., Fuchs, D., Wachter, H., & Daniel, M. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.902-912.1993 · Cited by 221 · cited 1×
“While Vpr enables robust T lymphocyte infection and rapid disease progression in vivo [2,3] and in ex vivo human lymphoid tissue [4], Vpr is dispensable and may actually be detrimental to HIV-1 replication in T lymphocytes in vitro [5–7].”
BackgroundLaguette, N., Brégnard, C., Hue, P., Basbous, J., Yatim, A., Larroque, M., Kirchhoff, F., Constantinou, A., Sobhian, B., & Benkirane, M. (2014) · Cell · doi:10.1016/j.cell.2013.12.011 · Cited by 212
Azzoni, L., Foulkes, A. S., Papasavvas, E., Mexas, A. M., Lynn, K. M., Mounzer, K., Tebas, P., Jacobson, J. M., Frank, I., Busch, M. P., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis663 · Cited by 189
Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection
Del Portillo, A., Tripodi, J., Najfeld, V., Wodarz, D., Levy, D. N., & Chen, B. K. (2011) · Journal of Virology · doi:10.1128/jvi.00231-11 · Cited by 170
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system
DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V. (2007) · Virology Journal · doi:10.1186/1743-422x-4-57 · Cited by 152 · cited 1×
“6 that is deficient at interacting with DCAF1 and relatively defective at inducing DCAF1-dependent cell cycle arrest [11,28].”
BackgroundDuncan, C. J. A., Williams, J. P., Schiffner, T., Gärtner, K., Ochsenbauer, C., Kappes, J., Russell, R. A., Frater, J., & Sattentau, Q. J. (2014) · Journal of Virology · doi:10.1128/jvi.03245-13 · Cited by 122
HIV-1 Vpr—a still “enigmatic multitaskerâ€
Guenzel, C. A., Hérate, C., & Benichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 120
Norman, J. M., Mashiba, M., McNamara, L. A., Onafuwa-Nuga, A., Chiari, E. F., Shen, W., & Collins, K. L. (2011) · Nature Immunology · doi:10.1038/ni.2087 · Cited by 111
Self-citationAhn, J., Vu, T., Novince, Z., Guerrero-Santoro, J., Rapic-Otrin, V., & Gronenborn, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133181 · Cited by 104
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies
Schiffner, T., Sattentau, Q. J., & Duncan, C. J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.020 · Cited by 104
Human Immunodeficiency Virus Type 1 Vpr Induces DNA Replication Stress InVitro and In Vivo
Zimmerman, E. S., Sherman, M. P., Blackett, J. L., Neidleman, J. A., Kreis, C., Mundt, P., Williams, S. A., Warmerdam, M., Kahn, J., Hecht, F. M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01212-06 · Cited by 103
Stivahtis, G. L., Soares, M. A., Vodicka, M. A., Hahn, B. H., & Emerman, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4331-4338.1997 · Cited by 102
Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr
Planelles, V, Bachelerie, F., Jowett, J. B., Haislip, A., Xie, Y., Banooni, P., Masuda, T., & Chen, I. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5883-5889.1995 · Cited by 92
Dendritic Cells and HIV-1 Trans-Infection
McDonald, D. J. (2010) · Viruses · doi:10.3390/v2081704 · Cited by 83
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys
Hoch, J., Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Dittmer, U., Hunsmann, G., Fuchs, D., Müller, J., & Sopper, S. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4807-4813.1995 · Cited by 83
Massanella, M., Puigdomènech, I., Cabrera, C., Fernandez-Figueras, M. T., Aucher, A., Gaibelet, G., Hudrisier, D., García, E., Bofill, M., Clotet, B., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32831ef1a3 · Cited by 81
Pertel, T., Reinhard, C., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-49 · Cited by 74
Vpr Overcomes Macrophage-Specific Restriction of HIV-1 Env Expression and Virion Production
Mashiba, M., Collins, D. R., Terry, V. H., & Collins, K. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.014 · Cited by 71 · cited 10×
“Because Vpr stimulates HIV-1 spread among MDM (Fig 2C) [11,24], it was possible that the stimulation of T lymphocyte infection we observed may result from an increase in the number of infected MDM that could amplify virus production.”
BackgroundInfluentialSelf-citationKlockow, L. C., Sharifi, H. J., Wen, X., Flagg, M., Furuya, A. K. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2013) · Virology · doi:10.1016/j.virol.2013.06.010 · Cited by 71
Durham, N. D., Yewdall, A. W., Chen, P., Lee, R., Zony, C., Robinson, J. E., & Chen, B. K. (2012) · Journal of Virology · doi:10.1128/jvi.00230-12 · Cited by 67
McNamara, L. A., Ganesh, J. A., & Collins, K. L. (2012) · Journal of Virology · doi:10.1128/jvi.00895-12 · Cited by 63
Self-citationSun, H., Buzón, M. J., Shaw, A., Berg, R., Yu, X. G., Ferrando‐Martínez, S., Leal, M., Ruíz-Mateos, E., & Lichterfeld, M. D. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit628 · Cited by 63
Giese, S., & Marsh, M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004189 · Cited by 63
HIV-1 Accessory Proteins Adapt Cellular Adaptors to Facilitate Immune Evasion
Collins, D. R., & Collins, K. L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003851 · Cited by 61
Self-citationMechanisms of enhanced HIV spread through T‐cell virological synapses
Dale, B. M., Alvarez, R. A., & Chen, B. K. (2013) · Immunological Reviews · doi:10.1111/imr.12022 · Cited by 60
Belzile, J.-P., Richard, J., Rougeau, N., Xiao, Y., & Cohen, E. A. (2010) · Journal of Virology · doi:10.1128/jvi.02590-09 · Cited by 49
Rücker, E., Grivel, J.-C., Münch, J., Kirchhoff, F., & Margolis, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12689-12693.2004 · Cited by 48
McCallus, D. E., Ugen, K. E., Sato, A. I., Williams, W. V., & Weiner, D. B. (1992) · Viral Immunology · doi:10.1089/vim.1992.5.163 · Cited by 44
Peressin, M., Proust, A. M., Schmidt, S., Su, B., Lambotin, M., Biedma, M. E., Laumond, G., Decoville, T., Holl, V., & Moog, C. (2014) · AIDS · doi:10.1097/qad.0000000000000193 · Cited by 38
Rockstroh, J. K., Mannah, M., Lichterfeld, M. D., Nischalke, H. D., Klausen, G., Gölz, J., Dupke, S., Notheis, G., Stein, L., & Mauss, S. (2002) · AIDS · doi:10.1097/00002030-200210180-00016 · Cited by 35
Molecular Mechanisms of HIV Immune Evasion of the Innate Immune Response in Myeloid Cells
Mashiba, M., & Collins, K. L. (2012) · Viruses · doi:10.3390/v5010001 · Cited by 29
Self-citationPersistent productive HIV-1 infection of a CD4- human fetal thymocyte line
Hatch, W. C., Tanaka, K. E., Calvelli, T. A., Rashbaum, W. K., Kress, Y., & Lyman, W. D. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3055 · Cited by 23
Vpr Overcomes Macrophage-Specific Restriction of HIV-1 Env Expression and Virion Production
Mashiba, M., Collins, D. R., Terry, V. H., & Collins, K. L. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.02.016 · Cited by 9
Self-citation
Cited by
Clayton, K., Collins, D. R., Lengieza, J., Ghebremichael, M. S., Dotiwala, F., Lieberman, J., & Walker, B. D. (2018) · Nature Immunology · doi:10.1038/s41590-018-0085-3 · Cited by 159
Self-citationHIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
Lahouassa, H., Blondot, M.-L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B. C., Schwartz, O., & Margottin-Goguet, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600485113 · Cited by 100
Lv, L., Wang, Q., Xu, Y., Tsao, L.-C., Nakagawa, T., Guo, H., Su, L., & Xiong, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.007 · Cited by 100
The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
González, M. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010126 · Cited by 94
HIV reprograms host m6Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1
Zhang, Q., Kang, Y., Wang, S., Gonzalez, G. M., Li, W., Hui, H., Wang, Y., & Rana, T. M. (2021) · Nature Communications · doi:10.1038/s41467-021-25683-4 · Cited by 70
Metadata
- Authors
- Collins, D. R., Lubow, J., Lukic, Z., Mashiba, M., & Collins, K. L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Collins, Kathleen L.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-07-17
- Volume
- 11
- Issue
- 7
- Pages
- e1005054
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4506080
- OpenAlex
- W2155484127
- Cited by
- 34
- References
- 51
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 2
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Burroughs Wellcome Fund
- University of Michigan
- National Institutes of Health (5t32ai007413-32, T32 AI00,7413)
- National Institute of General Medical Sciences (T32GM007863, T32GM008353, T32GM145304)
- National Institute of Allergy and Infectious Diseases (T32-AI-007413, R01AI046998, R56AI051192, T32AI007528, R01AI051192)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 Vpr, DCAF1, cell-to-cell viral spread, CD4+ T cells, virological synapse, HIV-1 envelope glycoprotein, LAMP1, lysosomal degradation, interferon-alpha, antiviral restriction
- MeSH terms
- Humans, Macrophages, Virion, CD4-Positive T-Lymphocytes, HIV-1, Interferon-alpha, vpr Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.